GLUE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Monte Rosa Therapeutics Inc

Watchlist Manager

Watchlist

Price: 12 USD 2.21% Market Closed

Market Cap: $1B

M	Monte Rosa Therapeutics Inc NASDAQ:GLUE	US
M	MBK PCL SET:MBK	TH
D	Domaine Power Holdings Ltd HKEX:442	HK
S	SG Co Ltd KOSDAQ:255220	KR
	Zhongchao Inc NASDAQ:ZCMD	CN
	News Corp F:NC0E	US
	Yiren Digital Ltd NYSE:YRD	CN
K	Konami Holdings Corp F:KOA	JP
B	Black Rock Coffee Bar Inc NASDAQ:BRCB	US
I	Industrial and Commercial Bank of China Ltd F:ICK	CN
R	Resmed Inc XMUN:RME	US
C	Cooper-Standard Holdings Inc F:C31	US
A	Atoss Software AG SWB:AOF	DE
C	Cadence Design Systems Inc F:CDS	US
	VVC Exploration Corp XTSX:VVC	CA

Profitability Summary

Monte Rosa Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-633%

Negative 3Y Average Operating Margin

-1.793%

Negative Net Margin

-561%

Negative 3Y Average Net Margin

-1.674%

Negative Free Cash Flow Margin

-112%

Negative 3Y Average Free Cash Flow Margin

-817%

Negative ROE

-43%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-145%

Declining ROIC

-197% > -283%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.